• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Trifluridine

CAS No. 70-00-8

Trifluridine ( NSC 75520 | NSC 529182 | TFT | Trifluridine )

产品货号. M15687 CAS No. 70-00-8

三氟胸苷 (TFT) 是胸苷磷酸化酶的抑制剂。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
50MG ¥117 有现货
100MG ¥197 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥131 有现货

生物学信息

  • 产品名称
    Trifluridine
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    三氟胸苷 (TFT) 是胸苷磷酸化酶的抑制剂。
  • 产品描述
    Trifluorothymidine (TFT) and is an inhibitor of thymidine phosphorylase. TFT also inhibits thymidylate synthase (TS), a rate-limiting enzyme of DNA biosynthesis, and is incorporated into DNA.
  • 体外实验
    Cell Viability Assay Cell Line:HUVEC cellsConcentration: 0-5 μM Incubation Time:3 days Result:Cell viability dropped sharply at 3 μM and 5 μM.Immunofluorescence Cell Line:HUVEC cells Concentration: 0-5 μM Incubation Time:3 days Result:Induced cellular senescence by inhibiting autophagy flux.Western Blot Analysis Cell Line:HUVEC cells Concentration: 0-5 μM Incubation Time:3 daysResult:Increased protein levels of senescence markers: p53, p16, SASP (IL-1, IL-6, TNF-α, p21).Cell Proliferation AssayCell Line:MCF-7, MDA-MB-231, BT-549, Hs578T and MCF-10A(control non-tumor) cells Concentration:5 μM-20 μM Incubation Time:24 h–72 h Result:Inhibited the proliferation of MDA-MB231, BT549 and Hs578T cells at 10μM and 20μM, significantly.Apoptosis AnalysisCell Line: MDA-MB-231, BT-549, and Hs578T cells Concentration:10μM or 20 μMIncubation Time:48 h Result:Increased the percentages of apoptotic TNBC cells (MDA-MB-231, BT-549, and Hs578Tcells) at 10μM and 20μM, significantly.
  • 体内实验
    Animal Model:Nude mice (human colorectal intraperitoneal xenograft model) Dosage: 200 mg/kg(trifluridine/tipiracil)Administration:Oral administration; Once a day; 5 days followed by 2 drug-free days, a total of 6 weeks Result:Exhibited a significantly longer survival time compared with untreated mice.Animal Model:Mouse model of breast cancerDosage:75 or 150 mg/kg Administration:Oral gavage; daily for 10 days Result:Treatment with different doses inhibited the growth of TNBC tumors in mouse in a dose-dependent mannerAnimal Model:The human gastric MKN45 intraperitoneal xenograft model Dosage:200 mg/kg (Trifluridine/tipiracil)Administration:twice daily for 5 consecutive days followed by 2 drug?free days for 6 weeks Result:Prolonged the survival of mice compared with untreated mice.
  • 同义词
    NSC 75520 | NSC 529182 | TFT | Trifluridine
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    DNA/RNA Synthesis
  • 受体
    DNA/RNA Synthesis| Thymidylate synthase
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    70-00-8
  • 分子量
    296.2
  • 分子式
    C10H11F3N2O5
  • 纯度
    >98% (HPLC)
  • 溶解度
    Ethanol: 59 mg/mL (199.18 mM); Water: 59 mg/mL (199.18 mM); DMSO: 59 mg/mL (199.18 mM)
  • SMILES
    O=C1NC(C(C(F)(F)F)=CN1[C@@H]2O[C@H](CO)[C@@H](O)C2)=O
  • 化学全称
    1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione.

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Shintani M, et al. Oncol Rep. 2010 May; 23(5):1345-50.
产品手册
关联产品
  • AVG-233

    AVG-233 是一种口服有效的 RNA 依赖性 RNA 聚合酶 (RdRp) 抑制剂。AVG-233 阻止启动子上的病毒聚合酶复合物的启动。AVG-233 结合位点存在于 L1-1749 片段中。AVG-233 对 RSV 毒株和临床分离株均具有纳摩尔活性 (EC50=0.14-0.31 μM)。AVG-233 可用于呼吸道合胞病毒 (RSV) 研究。

  • TH-588

    一种有效的选择性 MTH1 蛋白抑制剂,IC50 为 5 nM。

  • Ddr1-In-1

    DDR1-IN-1 是一种有效且特异性的 DDR1 受体酪氨酸激酶抑制剂 (IC50: 105 nM),选择性约为 DDR2 的 3 倍。